AH Capital Management,
$14.2B 13F equity value
19 Holdings
Quarter ended June 30, 2026
The latest 13F on file for AH Capital Management, covers the quarter ended June 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| SPCX | SPACE EXPLORATION TECHN CORP | 74,855,020 | $12.8B | 90.0% |
| NAVN | NAVAN INC | 28,218,676 | $645M | 4.5% |
| RVMD | REVOLUTION MEDICINES INC | 921,099 | $173M | 1.2% |
| META | META PLATFORMS INC | 212,531 | $120M | 0.8% |
| FIG | FIGMA INC | 5,983,308 | $108M | 0.8% |
| BIOA | BIOAGE LABS INC | 3,233,170 | $79M | 0.6% |
| XYZ | BLOCK INC | 1,016,697 | $77M | 0.5% |
| ERAS | ERASCA INC | 2,862,500 | $52M | 0.4% |
| MAZE | MAZE THERAPEUTICS INC | 1,702,225 | $51M | 0.4% |
| DMRA | DAMORA THERAPEUTICS INC | 1,236,157 | $32M | 0.2% |
Track AH Capital Management,'s 13F portfolio: $14.2B in reported holdings, 19 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}